<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-35585" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Retinal Hemorrhage</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kanukollu</surname>
            <given-names>Venkata M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Syed Shoeb</given-names>
          </name>
          <aff>Barkatullah University, Bhopal, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venkata Kanukollu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Syed Shoeb Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-35585.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Retinal hemorrhages are a common clinical manifestation in patients visiting an eye clinic. Retinal hemorrhages give a clue to an underlying systemic disorder or an uncontrolled ocular disorder. The extent, depth, and pattern of distribution of the hemorrhages give us a clue as to what might be the underlying cause. A detailed slit-lamp examination with fundus photography and an optical coherence tomography (OCT) scan is essential to diagnose the cause and help in deciding the various treatment options to prevent vision loss. This activity highlights the importance of an interprofessional team in the evaluation and treatment of retinal hemorrhages.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the different types of retinal hemorrhages.</p></list-item><list-item><p>Review the etiopathogenesis of retinal hemorrhages.</p></list-item><list-item><p>Summarize the different diagnostic methods for evaluating retinal hemorrhages.</p></list-item><list-item><p>Explain the role of an interprofessional team and how coordination is required with providers to manage the systemic disorders and with retinal surgeons to manage complications arising from the retinal hemorrhages.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35585&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35585">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-35585.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Retinal hemorrhages are an important ophthalmic diagnostic sign for an underlying systemic vascular disorder. They range from the smallest dot and blot hemorrhage to massive sub-hyaloid hemorrhage. The location, size, and distribution of the hemorrhages provide clues to the etiology and uncover underlying systemic disorders such as vascular disease, hematologic disorders, and dyscrasias, infections, trauma, or hypoxia. Rarely it can also be seen idiopathically. Most require a detailed systemic work up to detect the underlying cause for the hemorrhages. Management consists of observation, treating the primary cause, and intraocular management to reduce the ischemic and neovascularization sequelae following the hemorrhages.</p>
      </sec>
      <sec id="article-35585.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Following are the conditions which show retinal hemorrhages depending on the stage and severity of the disease:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ocular diseases: Age-related macular degeneration (ARMD),&#x000a0;polypoidal choroidal vasculopathy (PCV), juxta foveal telangiectasia, optic disc hemorrhages.</p>
          </list-item>
          <list-item>
            <p>Diabetic retinopathy: dot and blot and vitreous hemorrhages. Bilateral and diffusely distributed in the posterior pole.</p>
          </list-item>
          <list-item>
            <p>Hypertensive retinopathy: diffuse flame-shaped hemorrhages, preretinal hemorrhages seen rarely. Bilateral and diffusely distributed in the posterior pole.</p>
          </list-item>
          <list-item>
            <p>Retinal vein occlusions: diffuse intraretinal hemorrhages in all quadrants in central retinal vein occlusions and sectoral distribution in branch retinal vein occlusions.</p>
          </list-item>
          <list-item>
            <p>Trauma:&#x000a0;multilayered hemorrhages can be unilateral or bilateral, depending on the type of trauma. Preretinal hemorrhages are typical of Terson syndrome and Valsalva retinopathy. The shaken baby syndrome shows bilateral diffuse multilayered hemorrhages in infants and children. Birth trauma is the leading cause of neonatal retinal hemorrhages.</p>
          </list-item>
          <list-item>
            <p>Anemia: Roth spots, multilayered hemorrhages, subhyaloid hemorrhages, and vitreous hemorrhages. They are seen bilaterally and diffusely distributed.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Leukemia: Preretinal hemorrhages, vitreous hemorrhages, flame-shaped hemorrhages, intraretinal hemorrhages, Roth spots, and cotton wool spots, and. Sea-fan neovascularization is a typical finding. Bilaterally seen and diffusely distributed.</p>
          </list-item>
          <list-item>
            <p>Acute bacterial endocarditis: preretinal/vitreous, intraretinal, or flame-shaped hemorrhages in the parapapillary rim, cotton wool spots, Roth spots. They are bilaterally seen.</p>
          </list-item>
          <list-item>
            <p>Sickle cell anemia: SC and S-Thal variants lead to retinopathy, intraretinal salmon patch hemorrhages, black sunburst chorioretinal ischemic scars, and sea-fan neovascularization which might lead to vitreous hemorrhage. They are seen bilaterally.</p>
          </list-item>
          <list-item>
            <p>Ocular ischemic syndrome: Mid-peripheral intraretinal hemorrhages, retinal neovascularization.</p>
          </list-item>
          <list-item>
            <p>Preeclampsia: Intraretinal hemorrhages, Elschnig spots, with serous retinal detachment. They are seen bilaterally with varying intensity.</p>
          </list-item>
          <list-item>
            <p>Connective tissue disorders (lupus): intraretinal hemorrhage and vascular occlusions (severe stages) seen bilaterally.</p>
          </list-item>
          <list-item>
            <p>High altitude retinopathy: Roth spots, multilayered hemorrhages, and vitreous hemorrhages often seen bilaterally.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35585.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Retinal hemorrhages in critically ill children with no history of trauma or abuse have a prevalence of 15%. Most cases are mild and are seen in children younger than two years and are associated with systemic infection, accidental brain trauma, and severe coagulopathy.<xref ref-type="bibr" rid="article-35585.r1">[1]</xref>&#x000a0;Birth-related retinal hemorrhages are seen in 25% of newborns with normal delivery and 40% to 50% of newborns with instrumental deliveries.<xref ref-type="bibr" rid="article-35585.r2">[2]</xref>&#x000a0;Retinal hemorrhages were seen in 30% of physically abused children, and most are less than six months of age.<xref ref-type="bibr" rid="article-35585.r3">[3]</xref><xref ref-type="bibr" rid="article-35585.r4">[4]</xref> The prevalence of retinal hemorrhages in adults is most commonly seen after 40 years of age, as most systemic disorders are common in that age.</p>
      </sec>
      <sec id="article-35585.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Retinal hemorrhages are&#x000a0;classified according to the location in the retina: Retinal nerve fiber layer (RNFL), intraretinal, subretinal, subretinal pigment epithelium (RPE), subhyaloid/preretinal, and vitreous hemorrhage.<xref ref-type="bibr" rid="article-35585.r5">[5]</xref></p>
        <p>
<bold>Retinal Nerve Fiber Layer (RNFL) Hemorrhages</bold>
</p>
        <p>RNFL hemorrhages are superficial and follow the direction, shape, and spread of the RNFL bundles. Three types of hemorrhages are seen at the level of RNFL: flame-shaped hemorrhages, splinter (disc) hemorrhages, and Roth spots.</p>
        <list list-type="bullet">
          <list-item>
            <p>Flame shaped hemorrhages: These hemorrhages are diffuse, found in the posterior pole, and last approximately 6 to 12 weeks. They occur typically in diseases affecting superficial retinal capillary plexus secondary to arterial diseases like hypertension, blood dyscrasias, and anemias.</p>
          </list-item>
          <list-item>
            <p>Disc (Drance) hemorrhages: Theses are superficial splinter shaped hemorrhages located near the optic disc margin at the prelaminar level within one-disc diameter, usually with a tapered end towards the disc and feathery end away from the disc.<xref ref-type="bibr" rid="article-35585.r6">[6]</xref><xref ref-type="bibr" rid="article-35585.r7">[7]</xref> These are oriented perpendicular to the discs margin, found most commonly in inferotemporal in location, and are oriented along the retinal nerve fiber defect starting at the optic disc rim notch. Conditions causing disc hemorrhage are normal-tension glaucoma, primary open-angle glaucoma, posterior vitreous detachment, optic neuropathy, diabetes, anemia, hypertension, and retinal vascular disease.</p>
          </list-item>
          <list-item>
            <p>Roth spots: Roth spots are round in shape with a white center. It was Litten who described the association (Litten sign) and referred to it as Roth spots.<xref ref-type="bibr" rid="article-35585.r8">[8]</xref><xref ref-type="bibr" rid="article-35585.r9">[9]</xref><xref ref-type="bibr" rid="article-35585.r10">[10]</xref>&#x000a0;Capillary rupture with extravasation, and central fibrin&#x02013;platelet plug gives the white center to the Roth spot. Roth spots are characteristic of subacute bacterial endocarditis and also seen in leukemia, anemia, anoxia, and other rare conditions.</p>
          </list-item>
        </list>
        <p>
<bold>Intraretinal Hemorrhages</bold>
</p>
        <p>These dot and blot hemorrhages are found within the inner nuclear and outer plexiform layers of the retina. These are dense, dark red, sharply outlined, and are seen in disorders that affect the pre-venular deep capillary layer. Common causes for such hemorrhages include diabetic retinopathy, retinal vein occlusions, ocular ischemic syndrome, sickle cell retinopathy, and juxta foveal telangiectasia.<xref ref-type="bibr" rid="article-35585.r5">[5]</xref> Purtsher retinopathy is an occlusive microvasculopathy associated with cranial or thoracic compressive trauma.<xref ref-type="bibr" rid="article-35585.r11">[11]</xref>&#x000a0;Retinal findings are intraretinal whitening, cotton wool spots, and intraretinal hemorrhages. Purtscher-like retinopathy is seen in acute pancreatitis, renal failure, and autoimmune disease.</p>
        <p>
<bold>Subretinal Hemorrhages</bold>
</p>
        <p>These hemorrhages occur between the photoreceptor layer and retinal pigment epithelium (RPE). The hemorrhages are deep red in color and broader in shape with diffuse margins. Such hemorrhages are commonly seen in ARMD, presumed ocular histoplasmosis, high myopia, PCV, retinal macroaneurysm, and trauma. Sub-macular hemorrhages are commonly seen in choroidal neovascular membranes secondary to ARMD.<xref ref-type="bibr" rid="article-35585.r12">[12]</xref></p>
        <p>
<bold>Sub-RPE Hemorrhages</bold>
</p>
        <p>These hemorrhages are located between RPE and Bruch membrane and appear dark red with well-defined sharp borders. They are commonly seen in choroidal neovascular membranes (CNVM), choroidal tumors, and choroidal rupture secondary to acute trauma.</p>
        <p>
<bold>Sub-hyaloid or Preretinal Hemorrhages</bold>
</p>
        <p>Preretinal hemorrhages are &#x0201c;boat&#x0201d; or &#x02018;D&#x02019; shaped hemorrhages which collect between the posterior limiting membrane of the vitreous and internal limiting membrane (ILM) of the retina.<xref ref-type="bibr" rid="article-35585.r13">[13]</xref>&#x000a0;Causes include Terson syndrome, Valsalva retinopathy, proliferative diabetic retinopathy, and proliferative retinopathy after retinal vein occlusions. Terson syndrome is intraocular hemorrhage associated with subarachnoid hemorrhage, intracerebral hemorrhage, or traumatic brain injury.<xref ref-type="bibr" rid="article-35585.r14">[14]</xref>&#x000a0;Hemorrhage may be present in the vitreous, subhyaloid, or intraretinal /sub-internal limiting membrane. Valsalva retinopathy&#x000a0;is a pre-retinal hemorrhage caused by a sudden increase in intra-thoracic or intra-abdominal pressure.<xref ref-type="bibr" rid="article-35585.r15">[15]</xref><xref ref-type="bibr" rid="article-35585.r4">[4]</xref></p>
        <p>
<bold>Vitreous Hemorrhage (VH)</bold>
</p>
        <p>Bleeding into the vitreous cavity is seen as fresh blood clots with sudden onset of floaters.<xref ref-type="bibr" rid="article-35585.r16">[16]</xref> Chronic hemorrhages appear as diffuse vitreous clouding with settled blood inferiorly. They are commonly seen due to the rupture of a vessel, as seen commonly in proliferative diabetic retinopathy, retinal arteriolar microaneurysm, or during posterior vitreous detachment. A subretinal hemorrhage can cause a breakthrough bleeding into the vitreous. Breakthrough hemorrhage into vitreous also happens in malignant choroidal melanoma, retinal vascular occlusions, and idiopathic polypoidal choroidal vasculopathy (IPCV).</p>
        <p>
<bold>Shaken Baby Syndrome</bold>
</p>
        <p>This comes under abusive head trauma (AHT), is seen in young children caused by repeated acceleration-deceleration injury.<xref ref-type="bibr" rid="article-35585.r17">[17]</xref>&#x000a0;Characteristic clinical features include extensive bilateral multilayered retinal hemorrhages, intracranial injury (hemorrhage/hypoxic-ischemic injury), and occult fractures (ribs and long bone metaphysis).</p>
      </sec>
      <sec id="article-35585.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A detailed history about social conditions, medication use, abuse or trauma, recent Valsalva maneuvers or chest compression injury, flashes or floaters with a sudden transient dimming of vision, are all important to come to a diagnosis. All patients need a slit lamp examination of the anterior segment, dilated fundus examination, and intraocular pressure measurement. Optical coherence tomography (OCT), fundus fluorescein angiography (FFA), and fundus photography are all helpful to determine the location and depth of the hemorrhage. One should suspect abusive head trauma if a child less than three years shows retinal hemorrhages with an intracranial injury.<xref ref-type="bibr" rid="article-35585.r18">[18]</xref></p>
      </sec>
      <sec id="article-35585.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Blood pressure, body mass index, and blood sugar are mandatory before evaluating further. Also, the following workup would help in diagnosing the underlying systemic disorder leading to the retinal hemorrhages:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetes and metabolic syndromes: complete blood count and platelet count, erythrocyte sedimentation rate and C-reactive protein, fasting glucose and hemoglobin A1c and lipid profile.</p>
          </list-item>
          <list-item>
            <p>Hypercoagulable states: prothrombin time/ partial thromboplastin time, protein-C and -S, factor V Leiden, prothrombin gene mutation, homocysteine, antithrombin III, antiphospholipid antibodies.</p>
          </list-item>
          <list-item>
            <p>Systemic lupus erythematosus (SLE) and autoimmune workup: antinuclear antibody, anti-ds deoxyribonucleic acid (DNA), anti-nRNP antibody testing, anti-histone antibodies, anti-Ro/SS-A, anti-La/SS-B antibodies.</p>
          </list-item>
          <list-item>
            <p>Infective work up: ELISA, FTA-ABS/RPR.</p>
          </list-item>
          <list-item>
            <p>Masquerade syndrome: When the diagnosis is unclear, doing Lyme titers, herpes simplex titers, and FTA-ABS/RPR for syphilis will help in the diagnosis.</p>
          </list-item>
          <list-item>
            <p>Spondyloarthropathy: HLA-B5/B12: For conditions that present with anterior and posterior segment findings, one should rule out Behcet disease.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35585.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>A solitary retinal hemorrhage can be observed and followed up for progression in size and number. Hemorrhages that do not obscure or threaten vision do not warrant immediate treatment, and the primary systemic disorder causing the hemorrhages needs to be diagnosed and addressed. Direct intervention for retinal hemorrhages is indicated in submacular, subhyaloid, and vitreous hemorrhages because of their potential to damage vision irreversibly.</p>
        <p>Most dot and blot, splinter, and flame-shaped hemorrhages are not vision-threatening and are usually found in the posterior pole sparing the fovea and can be observed. Hemorrhages seen in retinal vein occlusions are not treated per se, but the retinal edema or the neovascularization, which follows as a sequela, needs to be treated. Roth spots are generally asymptomatic and typically resolve with treatment of the underlying disease, especially subacute bacterial endocarditis.</p>
        <p>Subhyaloid hemorrhage is seen typically in Terson syndrome and Valsalva retinopathy.<xref ref-type="bibr" rid="article-35585.r15">[15]</xref><xref ref-type="bibr" rid="article-35585.r14">[14]</xref><xref ref-type="bibr" rid="article-35585.r4">[4]</xref>&#x000a0;Besides, bilateral hemorrhages in the vitreous, sub-hyaloid, or intra-retinal hemorrhages are also seen. The first approach for a subhyaloid hemorrhage is always conservative observation. If no signs of resolution are seen within 1 to 3 months or for patients with high professional visual demand, Nd: YAG laser membranotomy is done to rupture the posterior hyaloid or the internal limiting membrane to drain the blood into vitreous. The blood settles into the inferior vitreous and out of the visual axis, prompting a rapid return of central visual acuity. Unresolved vitreous hemorrhage obstructing vision needs pars plana vitrectomy (PPV).</p>
        <p>Submacular hemorrhage (SMH)&#x000a0;is a sight-threatening complication that can occur in a CNVM secondary to exudative ARMD, PCV, high myopia, angioid streaks, and others. CNVM appears as a dirty grey-green color lesion, deep to the retina.<xref ref-type="bibr" rid="article-35585.r19">[19]</xref>&#x000a0;The grey-green appearance is believed to be due to the hyperplastic response of RPE. It may be accompanied by subretinal hemorrhage and/or lipid, serous or hemorrhagic PED, neurosensory exudate detachment, macular edema, and cystoid macular changes. Signs of choroidal neovascularization include RPE elevation, exudate, or subretinal fluid.</p>
        <p>Patients prone to develop CNVM are advised to self-check their retinal status weekly through Amsler grid charts. Any sudden onset of distortion of lines is suspicious of the development of CNVM. When left untreated, SMH causes irreversible vision loss by damaging the photoreceptors. The treatment strategies for SMH include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pneumatic displacement of SMH with or without tissue plasminogen activator (t-PA) displacement of blood from the fovea, usually by intravitreal injection of 0.3 to 0.4 ml of either shorter-acting sulfur hexafluoride (SF6) or longer-acting perfluoropropane (C3F8) followed by face-down head positioning for one to three days.</p>
          </list-item>
          <list-item>
            <p>Pharmacologic clot lysis such as with recombinant tissue plasminogen activator (r-tPA)</p>
          </list-item>
          <list-item>
            <p>Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents</p>
          </list-item>
          <list-item>
            <p>Pars plana vitrectomy with subretinal tPA/pneumatic gas displacement with and without post-operative anti-VEGF injections</p>
          </list-item>
        </list>
        <p>Vitreous hemorrhage<italic toggle="yes">&#x000a0;</italic>is commonly seen in vascular conditions such as diabetic retinopathy and retinal vein occlusions. The treatment strategies depending on the severity of hemorrhage and vision loss are as follows:<xref ref-type="bibr" rid="article-35585.r16">[16]</xref><xref ref-type="bibr" rid="article-35585.r20">[20]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Bed rest with head elevation helps reduce further bleeding. Bilateral eye patching helps in reducing eye movement, thereby settling the bleeding inferiorly, helping in a faster visual recovery.</p>
          </list-item>
          <list-item>
            <p>Avoid drugs like aspirin under physician supervision.</p>
          </list-item>
          <list-item>
            <p>Retinal breaks are closed by laser photocoagulation or cryotherapy (unlike cryotherapy, laser photocoagulation can close the compromised vessel in addition to the retinal tear), detached retinas are reattached with surgery, and proliferative retinal vascular diseases are treated with laser photocoagulation or cryotherapy.</p>
          </list-item>
          <list-item>
            <p>Surgical removal by Pars-Plana vitrectomy is indicated in patients with retinal detachment, unresolved VH for more than 2&#x000a0;to 3 months, VH with rubeosis, or Ghost cell glaucoma. Ghost cell glaucoma is a complication of long-standing vitreous hemorrhage wherein the hemoglobin-laden macrophages block the trabecular meshwork to cause raised intraocular pressure. Khaki-colored or red-tinged cells are seen floating in the anterior chamber, and reddish-brown discoloration of the trabecular meshwork is often present. The cells develop within 1 to 3 months of vitreous hemorrhage.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35585.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Since retinal hemorrhages can be found in both children and adults, therefore the differentials also vary according to the age group.</p>
        <p>Neonatal:&#x000a0;hemorrhages from birth trauma, including spontaneous vaginal delivery, vacuum extraction, and double instrument deliveries (vacuum and forceps).<xref ref-type="bibr" rid="article-35585.r2">[2]</xref></p>
        <p>Infants and Children:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ocular: Child abuse, Coat disease, persistent hyperplastic persistent vitreous, retinopathy of prematurity, retinal dysplasia, hypertension, myopia,</p>
          </list-item>
          <list-item>
            <p>Systemic: Hematological or cardiovascular disorder, infection, protein C deficiency.<xref ref-type="bibr" rid="article-35585.r21">[21]</xref></p>
          </list-item>
        </list>
        <p>Adults:</p>
        <p>Diabetes, hypertension, leukemia, blood dyscrasias, hypoxia/ anoxia/high altitudinal syndromes, high myopia, posterior vitreous detachment, retinal tear, and detachment.</p>
        <p>Roth spots:</p>
        <list list-type="bullet">
          <list-item>
            <p>Subacute bacterial endocarditis</p>
          </list-item>
          <list-item>
            <p>Leukemia</p>
          </list-item>
          <list-item>
            <p>Anemia</p>
          </list-item>
          <list-item>
            <p>Anoxia</p>
          </list-item>
          <list-item>
            <p>Carbon monoxide poisoning</p>
          </list-item>
          <list-item>
            <p>Prolonged intubation during anesthesia</p>
          </list-item>
          <list-item>
            <p>Preeclampsia</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Diabetic retinopathy</p>
          </list-item>
          <list-item>
            <p>HIV retinopathy</p>
          </list-item>
          <list-item>
            <p>Complicated labor and traumatic delivery in mothers and neonates</p>
          </list-item>
          <list-item>
            <p>Shaken baby syndrome</p>
          </list-item>
          <list-item>
            <p>Intracranial hemorrhage from arteriovenous malformation or aneurysm</p>
          </list-item>
          <list-item>
            <p>Acute reduction of intraocular pressure following trabeculectomy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35585.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most neonatal and infant retinal hemorrhages secondary to trauma have a good prognosis and resolve in 2&#x000a0;to 4 weeks. Retinal hemorrhages secondary to metabolic syndromes and venous occlusions resolve with control of the underlying conditions. Submacular and subretinal hemorrhages have a very poor prognosis and can irreversibly affect the vision due to damage to the photoreceptor layer. Subhyaloid hemorrhages, if ruptured by ND-YAG laser at an appropriate time, have a good prognosis. Most vitreous hemorrhages resolve within three months, and fine traces of blood clot can still be seen settled inferiorly. Unresolved hemorrhages or hemorrhages which cause secondary glaucoma carry a poor prognosis.</p>
      </sec>
      <sec id="article-35585.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Following are the complications that can arise secondary to retinal hemorrhages and underlying disorders:</p>
        <list list-type="bullet">
          <list-item>
            <p>Photoreceptor damage leading to permanent vision loss</p>
          </list-item>
          <list-item>
            <p>Neovascular and Ghost cell glaucoma</p>
          </list-item>
          <list-item>
            <p>Organized vitreous hemorrhage</p>
          </list-item>
          <list-item>
            <p>Submacular fibrosis</p>
          </list-item>
          <list-item>
            <p>Retinal neovascularization</p>
          </list-item>
          <list-item>
            <p>Vitreoretinal fibrovascular proliferation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35585.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <list list-type="bullet">
          <list-item>
            <p>Educate the patients about their retinal hemorrhages and the importance of keeping their underlying comorbid systemic conditions under control.</p>
          </list-item>
          <list-item>
            <p>Provide them with education leaflets and handover materials.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Explain to them about multidisciplinary liaison and how all the comorbidities are interlinked and how they influence one another.</p>
          </list-item>
          <list-item>
            <p>Inform the patients about the risk their retinal hemorrhages have over their vision and define the risks of progression and its consequences.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35585.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <list list-type="bullet">
          <list-item>
            <p>Discuss a follow-up or referral appointment to the clinic.</p>
          </list-item>
          <list-item>
            <p>Schedule the patient to return to the clinic if any new ocular symptoms or changes in vision occur between the appointments.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35585.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35585&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35585">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/retinal-hemorrhage/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=35585">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/35585/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=35585">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-35585.s15">
        <fig id="article-35585.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Eales Disease. Tuberculosis-delayed hypersensitivity uveitis (Eales disease) presenting with hemorrhagic ischemic vascular occlusion. Retinal hemorrhages, vascular obliteration, and sheathing temporal to the macula can also be seen. Contributed by AB Sallam, MD, PhD, FRCOphth</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ocular__TB__image__3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-35585.s16">
        <fig id="article-35585.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Retinal photograph of a patient with candidemia showing multiple retinal hemorrhages (arrows) and a Roth spot (arrow-head). Contributed by Ahmed Sallam, MD, PhD, FRCOphth</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fungal__endophthalmitis__figure__1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-35585.s17">
        <fig id="article-35585.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Figure 1: Retinal photograph of a patient with candidemia showing multiple retinal hemorrhages (arrows) and a Roth spot (arrow-head).
Figure 2: Raised chorioretinal Candida lesion in the active phase.
Figure 3: Healing chorioretinal Candida lesion with scarring and retinal traction. Contributed by Ahmed Sallam, MD, PhD, FRCOphth</p>
          </caption>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fungal__endophthalmitis__figure__1-3.mp4" mime-subtype="mp4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-35585.s18">
        <title>References</title>
        <ref id="article-35585.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agrawal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of retinal hemorrhages in critically ill children.</article-title>
            <source>Pediatrics</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>129</volume>
            <issue>6</issue>
            <fpage>e1388</fpage>
            <page-range>e1388-96</page-range>
            <pub-id pub-id-type="pmid">22614777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watts</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maguire</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Talabani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wiener</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kemp</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Newborn retinal hemorrhages: a systematic review.</article-title>
            <source>J AAPOS</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <page-range>70-8</page-range>
            <pub-id pub-id-type="pmid">23363882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Binenbaum</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mirza-George</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Christian</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Odds of abuse associated with retinal hemorrhages in children suspected of child abuse.</article-title>
            <source>J AAPOS</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-72</page-range>
            <pub-id pub-id-type="pmid">19541267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Valsalva retinopathy.</article-title>
            <source>Optom Vis Sci</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>91</volume>
            <issue>11</issue>
            <fpage>e278</fpage>
            <page-range>e278-81</page-range>
            <pub-id pub-id-type="pmid">25279780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Retinal haemorrhages.</article-title>
            <source>Arch Dis Child</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>1369</fpage>
            <page-range>1369-72</page-range>
            <pub-id pub-id-type="pmid">2103739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozturker</surname>
                <given-names>ZK</given-names>
              </name>
              <name>
                <surname>Munro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Optic disc hemorrhages in glaucoma and common clinical features.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>583</fpage>
            <page-range>583-591</page-range>
            <pub-id pub-id-type="pmid">29217027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uhler</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Piltz-Seymour</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Optic disc hemorrhages in glaucoma and ocular hypertension: implications and recommendations.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-94</page-range>
            <pub-id pub-id-type="pmid">18301280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loughrey</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Classical eye signs in bacterial endocarditis.</article-title>
            <source>QJM</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>108</volume>
            <issue>11</issue>
            <fpage>909</fpage>
            <page-range>909-10</page-range>
            <pub-id pub-id-type="pmid">25762500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ling</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>White-centred retinal haemorrhages (Roth spots).</article-title>
            <source>Postgrad Med J</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>74</volume>
            <issue>876</issue>
            <fpage>581</fpage>
            <page-range>581-2</page-range>
            <pub-id pub-id-type="pmid">10211348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khawly</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Pollock</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Litten's sign (Roth's spots) in bacterial endocarditis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1994</year>
            <month>May</month>
            <volume>112</volume>
            <issue>5</issue>
            <fpage>683</fpage>
            <page-range>683-4</page-range>
            <pub-id pub-id-type="pmid">8185527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miguel</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Henriques</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Azevedo</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Loureiro</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Maberley</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of Purtscher's and Purtscher-like retinopathies.</article-title>
            <source>Eye (Lond)</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">23174749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hochman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Seery</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Zarbin</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology and management of subretinal hemorrhage.</article-title>
            <source>Surv Ophthalmol</source>
            <year>1997</year>
            <season>Nov-Dec</season>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-213</page-range>
            <pub-id pub-id-type="pmid">9406367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mennel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Subhyaloidal and macular haemorrhage: localisation and treatment strategies.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>91</volume>
            <issue>7</issue>
            <fpage>850</fpage>
            <page-range>850-2</page-range>
            <pub-id pub-id-type="pmid">17576704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czorlich</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Skevas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Knospe</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vettorazzi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wagenfeld</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Westphal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Regelsberger</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury.</article-title>
            <source>Neurosurg Rev</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>129</fpage>
            <page-range>129-36; discussion 136</page-range>
            <pub-id pub-id-type="pmid">25173620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duane</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Valsalva hemorrhagic retinopathy.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1972</year>
            <volume>70</volume>
            <fpage>298</fpage>
            <page-range>298-313</page-range>
            <pub-id pub-id-type="pmid">4663671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saxena</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jalali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pathengay</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management of vitreous haemorrhage.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-96</page-range>
            <pub-id pub-id-type="pmid">12831156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mills</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Funduscopic lesions associated with mortality in shaken baby syndrome.</article-title>
            <source>J AAPOS</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-71</page-range>
            <pub-id pub-id-type="pmid">10530965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maguire</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pickerd</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Farewell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tempest</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kemp</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Which clinical features distinguish inflicted from non-inflicted brain injury? A systematic review.</article-title>
            <source>Arch Dis Child</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>94</volume>
            <issue>11</issue>
            <fpage>860</fpage>
            <page-range>860-7</page-range>
            <pub-id pub-id-type="pmid">19531526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitagawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shimada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yuzawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.</article-title>
            <source>Ophthalmology</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>6</issue>
            <fpage>1278</fpage>
            <page-range>1278-86</page-range>
            <pub-id pub-id-type="pmid">26949121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Morita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bando</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Emi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2013</year>
            <season>Jan-Mar</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-5</page-range>
            <pub-id pub-id-type="pmid">23580852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35585.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Fundus hemorrhages in infancy.</article-title>
            <source>Surv Ophthalmol</source>
            <year>1992</year>
            <season>Jul-Aug</season>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-17</page-range>
            <pub-id pub-id-type="pmid">1509354</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
